Correlation Between Verastem and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Verastem and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verastem and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Verastem and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Virpax Pharmaceuticals.
Diversification Opportunities for Verastem and Virpax Pharmaceuticals
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Verastem and Virpax is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Verastem i.e., Verastem and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Verastem and Virpax Pharmaceuticals
Given the investment horizon of 90 days Verastem is expected to generate 0.74 times more return on investment than Virpax Pharmaceuticals. However, Verastem is 1.34 times less risky than Virpax Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 273.00 in Verastem on September 16, 2024 and sell it today you would earn a total of 175.00 from holding Verastem or generate 64.1% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Verastem vs. Virpax Pharmaceuticals
Performance |
Timeline |
Verastem |
Virpax Pharmaceuticals |
Verastem and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Verastem and Virpax Pharmaceuticals
The main advantage of trading using opposite Verastem and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.Verastem vs. Puma Biotechnology | Verastem vs. Iovance Biotherapeutics | Verastem vs. Zentalis Pharmaceuticals Llc | Verastem vs. Syndax Pharmaceuticals |
Virpax Pharmaceuticals vs. Puma Biotechnology | Virpax Pharmaceuticals vs. Iovance Biotherapeutics | Virpax Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Virpax Pharmaceuticals vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Fundamental Analysis View fundamental data based on most recent published financial statements |